Is a Correction Looming Ahead for Allena Pharmaceuticals Inc. (ALNA) – News Heater
Home  »  Business   »  Is a Correction Looming Ahead for Allena Pharmaceu...

Is a Correction Looming Ahead for Allena Pharmaceuticals Inc. (ALNA)

Allena Pharmaceuticals Inc. (NASDAQ:ALNA) went up by 10.58% from its latest closing price compared to the recent 1-year high of $1.45. The company’s stock price has collected 9.94% of gains in the last five trading sessions.

Is It Worth Investing in Allena Pharmaceuticals Inc. (NASDAQ :ALNA) Right Now?

Plus, the 36-month beta value for ALNA is at 1.75. Opinions of the stock are interesting as 0 analysts out of 3 who provided ratings for Allena Pharmaceuticals Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The average price from analysts is $0.50, which is $2.12 above the current price. ALNA currently public float of 88.66M and currently shorts hold a 2.95% ratio of that float. Today, the average trading volume of ALNA was 10.57M shares.

ALNA’s Market Performance

ALNA stocks went up by 9.94% for the week, with a monthly jump of 10.77% and a quarterly performance of -52.94%, while its annual performance rate touched -90.10%. The volatility ratio for the week stands at 10.22% while the volatility levels for the past 30 days are set at 13.13% for Allena Pharmaceuticals Inc. The simple moving average for the period of the last 20 days is 9.71% for ALNA stocks with a simple moving average of -73.90% for the last 200 days.

Analysts’ Opinion of ALNA

Many brokerage firms have already submitted their reports for ALNA stocks, with H.C. Wainwright repeating the rating for ALNA by listing it as a “Buy.” The predicted price for ALNA in the upcoming period, according to H.C. Wainwright is $10 based on the research report published on June 01st of the previous year 2020.

Robert W. Baird gave a rating of “Outperform” to ALNA, setting the target price at $20 in the report published on January 18th of the previous year.

ALNA Trading at -8.46% from the 50-Day Moving Average

After a stumble in the market that brought ALNA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.85% of loss for the given period.

Volatility was left at 13.13%, however, over the last 30 days, the volatility rate increased by 10.22%, as shares surge +19.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -43.53% lower at present.

During the last 5 trading sessions, ALNA rose by +9.94%, which changed the moving average for the period of 200-days by -87.71% in comparison to the 20-day moving average, which settled at $0.1220. In addition, Allena Pharmaceuticals Inc. saw -77.60% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ALNA starting from BRENNER LOUIS MD, who sale 40,328 shares at the price of $0.81 back on Nov 15. After this action, BRENNER LOUIS MD now owns 288,576 shares of Allena Pharmaceuticals Inc., valued at $32,666 using the latest closing price.

Stock Fundamentals for ALNA

Equity return is now at value -284.00, with -149.50 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 2.11.